Which companies disclosed the most to Open Payments

Which companies disclosed the most to Open Payments

By Art Golab and Michael Sandler  |  June 30, 2015

Genentech, the maker of Avastin and other expensive cancer drugs, paid physicians and teaching hospitals more than any other drug or device company in 2014, according to a new round of data posted to the CMS' Open Payments website.

CBO: 21st Century Cures will cost $106 billion

By Steven Ross Johnson  |  June 24, 2015

The 21st Century Cures Act, a fast-moving bill aimed at fueling medical innovation, would cost $106 billion to implement and its cost-saving provisions—including limiting Medicaid pay for durable medical equipment—would yield $12 billion over the next decade, according to the CBO.

FDA approves blood clot prevention drug Kengreal

FDA approves blood clot prevention drug Kengreal

By Steven Ross Johnson  |  June 23, 2015

Federal regulators on Monday approved the blood clot prevention drug Kengreal made by the Medicines Co. for patients undergoing angioplasty procedures. The approval comes after a decade and $200 million were spent developing the drug.

Clinical trial for experimental Ebola drug halted

By Steven Ross Johnson  |  June 22, 2015

Clinical drug trials of an experimental treatment for Ebola have stopped after it was found unlikely to be effective. Health officials have been looking to abate the effects of the virus strain that has ravaged West Africa for more than a year.

Cost, value of treatments for common cancers compared

Cost, value of treatments for common cancers compared

By Sabriya Rice  |  June 22, 2015

A new tool will allow oncologists to compare various drug treatments for four common cancers based on survival, side effects and costs. The framework is part of a broader effort to help physicians and patients choose appropriate therapies amid the skyrocketing costs of cancer drugs.

First generic for MS drug Copaxone launches in U.S.

By Steven Ross Johnson  |  June 19, 2015

The first approved generic of the multiple sclerosis drug Copaxone launched this week after a federal appeals court upheld a ruling Thursday that drugmaker Teva Pharmaceuticals' patent on its best-selling drug was invalid. The generic Glatopa's cost per month is estimated at $5,000, compared with...

Allergan to buy Kythera for $2 billion

By Steven Ross Johnson  |  June 17, 2015

Dublin-based Botox maker Allergan has agreed to acquire Kythera Biopharmaceuticals for more than $2 billion. Allergan hopes to bank on the medical cosmetic drug firm's recently approved treatment for double chins.

Upton aiming for 80% of House to back 21st Century Cures

By Virgil Dickson  |  June 16, 2015

House Energy and Commerce Committee Chairman Fred Upton (R-Mich.) is aiming to have as many as 350 votes or 80% of the members of the House supporting the 21st Century Cures Act, also known as H.R. 6.

Two new cholesterol drugs raise questions of cost and access

By Steven Ross Johnson  |  June 10, 2015

FDA advisory panels this week recommended approval of two drugs that may significantly lower cholesterol. But experts warn the potential high cost for these blockbuster drugs could limit their access and once again raise concerns about skyrocketing prescription costs.

Bayer unloads diabetes-care business for $1.1 billion

By Michael Sandler  |  June 10, 2015

Bayer on Wednesday announced it is selling its diabetes-care business to Panasonic Healthcare Holdings Co., in a deal valued at just over $1.1 billion (1 billion euros). The German drugmaker is focusing on prescription and over-the-counter drugs, as well as its crop science business.

Blockbuster drugs to drain payers' finances, report says

By Bob Herman  |  June 09, 2015

The costs of prescription drugs have grown more quickly than any other part of the healthcare industry, and a new report estimates a small portion of breakthrough specialty drugs will further strain the budgets of federal and state healthcare programs.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.